TrialBlood cancer journal2022

High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study.

Jun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.